Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer
International Journal of Cancer, 04/27/2012
Chung FT et al. – Tumor–associated macrophages (TAMs) are related to treatment response irrespective of EGFR mutation and can independently predict survival in advanced non–small cell lung cancer (NSCLC) treated with an epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR–TKIs).
